Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? MarketBeat compares G Medical Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with G Medical Innovations include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to T2 Biosystems?

G Medical Innovations (NASDAQ:GMVDF) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
T2 Biosystems Neutral

G Medical Innovations has a beta of 27.28, suggesting that its stock price is 2,628% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.71, suggesting that its stock price is 671% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
T2 Biosystems$7.68M0.01-$50.08M-$3.89N/A

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 7 factors compared between the two stocks.

How does G Medical Innovations compare to SmileDirectClub?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

G Medical Innovations (NASDAQ:GMVDF) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
ViewRay N/A N/A N/A

G Medical Innovations has a beta of 27.28, meaning that its stock price is 2,628% more volatile than the broader market. Comparatively, ViewRay has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 2.5% of ViewRay shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

G Medical Innovations has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
ViewRay$102.21M0.00-$107.33M-$0.31N/A

In the previous week, ViewRay had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for ViewRay and 0 mentions for G Medical Innovations. G Medical Innovations' average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
ViewRay Neutral

Summary

G Medical Innovations and ViewRay tied by winning 3 of the 6 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Acutus Medical has a beta of 5.67, suggesting that its share price is 467% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, suggesting that its share price is 2,628% more volatile than the broader market.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
G Medical Innovations Neutral

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
G Medical Innovations N/A N/A N/A

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

G Medical Innovations (NASDAQ:GMVDF) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

G Medical Innovations has a beta of 27.28, suggesting that its stock price is 2,628% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Minerva Surgical N/A N/A N/A

6.0% of G Medical Innovations shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Minerva Surgical Neutral

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$26K$46.05M$7.16B$12.48B
Dividend YieldN/A1.08%2.66%6.52%
P/E RatioN/A20.7528.0224.70
Price / SalesN/A31.08540.5599.42
Price / CashN/A18.8649.2657.09
Price / BookN/A8.4610.966.46
Net Income-$24.63M-$20.01M$3.57B$337.01M

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
TTOO
T2 Biosystems
N/A$0.00
+233.3%		N/A-98.6%$42K$7.68MN/A180
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel